Melanoma vaccine study pulled before it even started
NCT ID NCT01861938
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 33 times
Summary
This study aimed to test a special vaccine made from modified tumor cells to help the immune system fight melanoma in patients at high risk of the cancer coming back. It was designed for people with certain genetic markers and advanced stages of melanoma. However, the study was withdrawn before any participants were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH RISK HLA-A2+ MELANOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.